You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
A new microfluidic chip analyzes urine samples to detect prostate cancer cells.
New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma
A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis
The inventors of new diagnostic technologies discuss their innovations and how they can move laboratory medicine forward
A new funding boost looks set to facilitate the deployment of the world’s first saliva-based rapid diagnostic test for malaria
A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment
Jennifer Van Eyk
Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation
Simple, accurate, and reproducible methods can help with treatment selection and resistance detection via liquid biopsy
The transcriptome of circulating neutrophils may contain a signature that allows the early detection of intracranial aneurysms via blood test
Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.